Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HGS CEO hails from TAP

Executive Summary

Former TAP Pharmaceuticals President Thomas Watkins joins Human Genome Sciences as CEO. Watkins worked for Abbott-affiliated companies for almost 20 years, including six years serving as president of the Takeda/Abbott joint venture; his term as president was limited by the joint venture agreement (1"The Pink Sheet" Sept. 6, 2004, p. 8). Watkins replaces former HGS CEO William Haseltine, PhD, who also retired as chairman; Argeris Karabelis, PhD, became chairman Oct. 17...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS045032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel